FUBROGONIUM

Details

Stereochemistry	RACEMIC
Molecular Formula	C14H23BrNO3
Molecular Weight	333.241
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	1

SHOW SMILES / InChI

Structure Search

SMILES

CC[N+](C)(CC)CCC(C)OC(=O)C1=CC=C(Br)O1

InChI

InChIKey=BARVHWUQZBZQAP-UHFFFAOYSA-N

InChI=1S/C14H23BrNO3/c1-5-16(4,6-2)10-9-11(3)18-14(17)12-7-8-13(15)19-12/h7-8,11H,5-6,9-10H2,1-4H3/q+1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13865362 | https://www.ncbi.nlm.nih.gov/pubmed/13931046 | https://www.webapteka.ru/drugbase/name7133.html

Fubromegan, a ganglionic blocking agent as an iodide salt, FUBROGONIUM IODIDE was used in Russia in patients with peptic ulcer and in the symptomatic therapy of patients with pneumoconioses. The antispasmodic effect of fubromegan was due to the effect on m- and n-cholinergic structures of smooth muscles and ganglia.

Approval Year

PubMed

Title	Date	PubMed
[Roentgenological studies on the effect of fubromegan in dyskinesias of the biliary tract].	1961	14481654

Patents

Sample Use Guides

In Vivo Use Guide

the initial dosage: 30 mg with increasing up to 60-100 мmg. 2-3 times/day during 2-3 weeks

Route of Administration: Oral

Name

Type

Language

FUBROGONIUM

Common Name

English

FUBROGONIUM CATION

Common Name

English

DIETHYL (3-HYDROXYBUTYL)METHYLAMMONIUM 5-BROMO-2-FUROATE

Systematic Name

English

1-BUTANAMINIUM, 3-(((5-BROMO-2-FURANYL)CARBONYL)OXY)-N,N-DIETHYL-N-METHYL

Common Name

English

FUBROGONIUM ION

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C66886